UK signs deal with GlaxoSmithKline to ‘fill and finish’ 60million doses of Novavax’s Covid vaccine
The Government has agreed a deal with pharmaceutical giant GlaxoSmithKline (GSK) on the manufacture of up to 60 million doses of the Novavax coronavirus vaccine. Here is what we know: – How does the vaccine work? The Novavax vaccine works like other vaccines by teaching the immune system to make antibodies to the coronavirus spike … Read more